01 8ALKERMES INC
01 810716785
01 8Blank
01 8Blank
01 82031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3136
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3137
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3137
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3137
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3136
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3136
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3137
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
Patent Expiration Date : 2031-08-23
OLANZAPINE; SAMIDORPHAN L-MALATE
US Patent Number : 10716785
Drug Substance Claim :
Drug Product Claim :
Application Number : 213378
Patent Use Code : U-3136
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-23
